Volume : 09, Issue : 03, March – 2022
Title:
18.ETHNO-PHARMACOLOGY, THERAPEUTICS, PHARMACOKINETICS, AND TOXICOLOGY OF SAMM-UL-FAR (ARSENIC) IN TRADITIONAL MEDICINE: A NARRATIVE REVIEW
Authors :
Bhoraniya Abdullah Ismail *, Mohammad Nawab, Juveria Jabeen , Ansari Umme Ammara Maqbool Ahmad , Qamar Uddin, Ahmed Minhajuddin
Abstract :
In traditional systems of medicine herbs, minerals, and animal sources are in used as medicine since antiquity. In the Unani system of medicine gold, silver, iron, copper, zinc, lead, salts, earthy matters, gems, arsenic, borax, etc. are used in the various formulation in different forms after the process of detoxification. Samm-ul-Far (Arsenic) is a naturally occurring odorless and tasteless element found in the ores of silver in the island and mountains of Khurasan. Chemically, Samm-ul-Far (SF) is arsenic trioxide. Unani formulations of SF is used in various disease especially nervine disorders, skin disease, sexual disorders, arthritis, blood infection, and blood dyscrasia. Since it is having a 4th degree of hot and dry temperament it is used with caution and diligently even in therapeutic doses. In this review, information related to the history of medicinal use, Ethno-pharmacology, medicinal importance, toxicity study, formulation of arsenic, the pharmacokinetics of arsenic, therapeutic actions, and use of arsenic trioxide in the current scenario has been described. From the review with evidence, it may conclude that the risk-benefit ratio (more risk than benefit) should be kept in mind while using SF as medicine even at a therapeutic dose.
Keywords: Arsenic trioxide, Samm-ul-Far, Unani Medicine, Toxicity, Ethno-Pharmacology, Pharmacokinetics, Purification
Cite This Article:
Please cite this article in press Bhoraniya Abdullah Ismail et al, Ethno-Pharmacology, Therapeutics, Pharmacokinetics, And Toxicology of Samm-ul-Far (Arsenic) In Traditional Medicine: A Narrative Review., Indo Am. J. P. Sci, 2022; 09(3),.
Number of Downloads : 10
References:
1. Anonymous. National Formulary of Unani Medicine. Part II. Vol. 01. New Delhi; CCRUM: Ministry of Health and Family Welfare, Govt, of India; 2007 Aug: 159.
2. Ghani N. Khazain-al-Advia. 1st Ed. New Delhi: Idarah Kitab al Shifa; YNM: 61, 63, 840 – 842.
3. Khan MA. Muheet-e-Azam. Kanpur: Matba Nizami; 1313 AH: 54.
4. Emma Lynch, Robin Braithwaite. A review of the clinical and toxicological aspects of ‘traditional’ (herbal) medicines adulterated with heavy metals. Expert Opinion on Drug Safety, 2005;4(4): 769- 778. http://dx.doi.org/10.1517/14740338.4.4.769 PMid:16011453
5. Gogtay NJ, Bhatt HA, Dalvi SS, Kshirsagar NA. The use and safety of non-allopathic Indian medicines. Drug Saf, 2002;25(14):1005-19. http://dx.doi.org/10.2165/00002018-200225140-00003 PMid:12408732
6. Saper RB, Kales SN, Paquin J et al. Heavy metal content of Ayurvedic herbal products. JAMA, 2004;292 (23):2868-2872. http://dx.doi.org/10.1001/jama.292.23.2868 PMid:15598918
7. Panda AK, Jay Krishnan KT. Consumer demand on traditional Medicine in Chennai Rural. Aryavidyan 2006; XIX (3)
8. Zhang P, Wang SY and Hu XH. Arsenic trioxide treated 72 cases of acute promyelocytic leukemia. Chin. J. Hematol., 1996;17: 58–62.
9. Athar Parvez Ansari, Abdul Wadud, Najeeb Jahan, Shamim Irshad, Uzma Jabeen. Standardization of Kushta Sammul far (Calx of Arsenic Trioxide) Prepared by Two Different Methods. Hippocratic Journal of Unani Medicine. July – September 2012; 7 (3),133-140.
10. Hughes MF. Arsenic toxicity and potential mechanism of action. Toxicology Letters.2002; 133: 1-16.
11. Mandal BK and Suzuki KT. Arsenic round the world: a Review. Talanta.2002; 58: 201-235.
12. Lendberg AL and Vahter M. Health effect of inorganic arsenic. Arsenic in ground water- A world problem: PNM; YNM: 64-81.
13. Ratnaike RN. Acute and Chronic arsenic toxicity. Postgrad. Med. J. 2003; 79, 391-396.
14. Kabeeruddin HM. Ilmul Advia Nafeesi. New Delhi: Aijaz Publishing House; 2007: 294-295.
15. Hakim MAH. Bustan al-Mufradat. New Delhi: Idarah Kitab al Shifa; 2002 June: 349, 350.
16. Kabeeruddin HM, Makhzan al-Mufradat. New delhi: Idarah Kitab al Shifa; 2007: 262.
17. Anonymous. Qarabadeen-e-Sarkari. 2nd Ed. New Delhi: CCRUM: Ministry of Health and Family Welfare, Govt. of India; 2006: 91.
18. Siddiqi MJ. Kitab al-Samum. New Delhi: Jamia Hamdard; 2003: 65-67.
19. Ibn Baitar. Al-Jame al-Mufradat al-Advia wa al-Aghzia. Vol. 03. (Urdu translation by CCRUM). New Delhi: Dept. of AYUSH, Ministry of Health and Family Welfare, Govt. Of India; 1999: 146.
20. Khan MA. Asma-al-Advia. (Edited by Rahman SZ). Aligarh: Publication Division AMU; 2002: 156.
21. Al- Attar Z. Ikhtiyarat-e-Badiei. Lucknow: Nawal Kishore; 1305 AH: 288.
22. Tarique NA. Taj-al-Mufradat. New Delhi: Idarah Kitab al Shifa; 2010 Jan: 465, 466.
23. Feerozuddin M. Feeroz al-Lughat. Delhi: Educational Publishing House; 2003: 813
24. Ali H. Majma al-Bahren. Lucknow: Munshi Nawal kishore; YNM: 4, 156.
25. Hafeez A. Risala Sankhiya. Delhi: Jamiat al-Atibba, Qarol Bagh; 1930: 04, 05.
26. Ali A and Mustahsan. Advia Ma’dania. New Delhi: Aijaz Publishing House; 2004: 47, 48.
27. Ibn Umar. Tazkara Uool-al-Albab. Lebnone: Dar al Kitab al Ilmia; 1998: 491.
28. Khan MS. Taleef-e-Shareefi. Delhi: Matba Dar al Salam; YNM: 149.
29. MÔmin HMM. Tohfat al-Momineen. Lucknow: Nawal Kishore; YNM: 12, 13, 161.
30. Qarshi HMH. Silk-e-Marwareed. New Delhi: Aijaz Publishing House; 1996 March: 106-108.
31. Anonymous. Physicochemical Standards of Unani Formulations. Part IV: New Delhi: CCRUM: Ministry of Health and Family Welfare, Govt. of India; 2006: 09.
32. Tabri R. Firdos al-Hikmat. (Urdu translation by Faisal Publication). Deoband; 2002: 367.
33. Shameem I. Wadud A, Janha N. Temperature Standardization and Comparative Toxicity study of Kushta Sammul far prepared by different methods. (Thesis submitted to Dept. of Ilmul Advia, NIUM) Bangalore. 2009: 11, 12, 35, 36, 45, 46, 50.
34. Anonymous. National Formulary of Unani Medicine. Part I. New Delhi: CCRUM: Ministry of Health and Family Welfare, Govt. of India; 2006: 76.
35. Anonymous. National Formulary of Unani Medicine. Part – I I, Volume – I. New Delhi: Ministry of Health & Family Welfare, Government of India; 2007:159,163.
36. Feerozuddin M. Madan al-Akseer. Lahore: Rafahe Aam Press; 1909: 14, 16.
37. Kabeeruddin HM. Bayaz-e-Kabeer. Vol.01. Lahore: Siddiqi Publications; YNM: 291.
38. Khan A. Khulasat al-Tajarib. Lucknow: Nawal Kishore; 1875: 573.
39. Sadiq SM. Anees al-Atibba. Lucknow: Samare Hind; 1875: 141.
40. Ferreccio C, Yuan Y, Calle J, Benítez H, Parra RL, Acevedo J, et al. Arsenic, tobacco smoke, and occupation: associations of multiple agents with lung and bladder cancer. Epidemiology. 2013;24(6): 898–905.
41. Gibb H, Haver C, Gaylor D, Ramasamy S, Lee JS, Lobdell D, et al. Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic. Environ Health Perspect. 2011;119(3):284–90.
42. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, HertzPicciotto I, Duggan HM, et al. Cancer risks from arsenic in drinking water. Environ Health Perspect. 1992; 97:259–67.
43. Parvez F, Wasserman GA, Factor-Litvak P, Liu X, Slavkovich V, Siddique AB, et al. Arsenic exposure and motor function among children in Bangladesh. Environ Health Perspect. 2011;119(11): 1665–70.
44. Parvez F, Chen Y, Brandt-Rauf PW, Slavkovich V, Islam T, Ahmed A, et al. A prospective study of respiratory symptoms associated with chronic arsenic exposure in Bangladesh: findings from the health effects of arsenic longitudinal study (HEALS). Thorax. 2010;65(6):528–33.
45. States JC, Srivastava S, Chen Y, Barchowsky A. Arsenic and cardiovascular disease. Toxicol Sci. 2009;107(2):312–23.
46. Rahman A, Vahter M, Ekström EC, Persson LÅ. Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Environ Health Perspect. 2011;119(5):719–24.
47. Islam MR, et al. Association between type 2 diabetes and chronic arsenic exposure in drinking water: a cross sectional study in Bangladesh. Environmental Health: A Global Access Science Source, 2012. 11(1).
48. Kozisek F. Regulatory aspects of arsenic in drinking water. In: Bhattacharya P, Polya DA, Jovanovic D, editors. Best practice guide on the control of arsenic in drinking water. London: IWA Publishing; 2017.
49. Schmidt CW. Low-dose arsenic: in search of a risk threshold. Environ Health Perspect. 2014;122(5): A131–4.
50. Ahmad A, Bhattacharya P. Arsenic in Drinking Water: Is 10 μg/L a Safe Limit. Current Pollution Reports. 2019; 5:1–3. https://doi.org/10.1007/s40726-019-0102-7
51. Goldman L, Ausiello D. CECIL Textbook of Medicine. 22th Ed. Vol.01. Pennsylvania: Saunders; 2004: 94-95.
52. Ali Moghaddam K. A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia. International Journal of Hematology- Oncology and Stem Cell Research. July 1, 2014: 8(3);45-54.
53. Chung I Y, Yu S D, Hong Y S. Environmental Source of Arsenic Exposure. J Prev Med Public Health., 2014; 47:253-257.
54. Siddiqui, R., Vohra, D. and Vohra, S.B. Proconvulsant effects of calcined arsenic preparations used in Unani Medicine, Indian Journal of Pharmacology. 1999; 31(2): 150-152.